Director Rhys J. Best bought 1,500 shares of ACA at $79.84 on 2025-03-05, expanding position to 58,195 shares (+2.6%).
Director Rhys J. Best purchased 1,500 shares at $79.84, a price now below the current market level of $82.34, yet substantially below the 52-week high of $111.57, reflecting a recent decline of -26.2% from peak. The buy adds to an existing position of 56,695 shares (56.7K shares), increasing total holdings by 2.6%. However, this purchase must be evaluated against the insider's cross-ticker track record: his prior buy transactions show an average 90-day return of -90.0% with a 0.00% win rate, indicating a historically poor record of buy timing across all holdings. While the P/E of 63.83 and positive revenue growth of +11.4% suggest underlying operational stability, the director's transaction footprint elsewhere raises questions about the predictive value of his recent entry at a depressed price level.